Pfizer Inc.
Compare this stock
PFE Stock Report Card
$
58%
Performance
Score:
10/100
PFE returned -36.05% in the last 12 months. Based on SPY's performance of -21.29%, its performance is below average giving it a score of 10 of 100.
Analyst Price Targets
Score:
63/100
22 analysts offer 12-month price targets for PFE. Together, they have an average target of 60.44, the most optimistic target put PFE at 141.39 within 12-months and the most pessimistic has PFE at 44.
Sentiment
Score:
70/100
PFE had a bullish sentiment score of 69.84% across Twitter and StockTwits over the last 12 months. It had an average of 317.89 posts, 5,792.02 comments, and 19,827.59 likes per day.
Technicals
Score:
11/100
PFE receives a 10 of 100 based on 14 indicators. 1 are bullish, 12 are bearish.
Earnings
Score:
74/100
PFE has missed earnings 2 times in the last 20 quarters.
Profit
Score:
68/100
Out of the last 20 quarters, PFE has had 17 profitable quarters and has increased their profits year over year on 8 of them.
Volatility
Score:
43/100
PFE has had a lower than average amount of volatility over the last 12 months giving it a score of 42 of 100.
Dividend
Score:
97/100
PFE's most recent dividend was $0.32 per share, based on a share price of $30.11. It was a payout ratio of 48.46% compared to their total earnings.
Pfizer Inc. Summary
New York Stock Exchange / PFE
Healthcare
Drug Manufacturers - General
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Checkout Similar Companies
PFE scored highly on our reportcard. Here are some similar companies and how they performed.
